![]() |
市场调查报告书
商品编码
1383342
至 2030 年色素沉着过度治疗市场预测:按类型、适应症、最终用户和地区分類的全球分析Hyperpigmentation Treatment Market Forecasts to 2030 - Global Analysis By Type, Indication, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球色素沉着过度治疗市场规模为 47.8 亿美元,预计在预测期内将以 10.5% 的年复合成长率增长,到 2030 年达到 96.1 亿美元。
色素沉淀一词描述了由于黑色素(赋予皮肤颜色的色素)过多而导致的某些肤色区域变黑。许多因素都会对色素沉淀产生影响,包括荷尔蒙、紫外线照射、发炎和皮肤创伤。色素沉着过度治疗的主要目标通常是均匀肤色并减少或去除多余的色素。
根据 2022 年 4 月发布的美容整形外科国家资料库,2021 年美国进行了 1,390,149 例化学换肤和水面部护理等皮肤治疗以及 431,485 例组合雷射治疗。
随着我们对皮肤健康认识的提高,人们正在采取预防措施来预防皮肤劣化。这包括采取预防措施,防止阳光引起的色素沉着,例如使用防晒油、穿着防护衣和留在阴凉处。实施全面的皮肤健康计划提倡早期诊断和治疗色素沉着相关疾病。当人们出现色素沉淀问题时,他们更有可能立即寻求专业建议和治疗。对皮肤健康的认识培养了自我保健的文化。人们更有可能使用针对色素沉着和改善整体皮肤健康的皮肤护理程序。
顾客可能会因产品的负面影响而在心理和身体上遭受痛苦。这些包括烧烫伤、皮肤粗糙、过敏反应和色素沉着增加。对于接受治疗的人来说,这些副作用可能会导致疼痛、不适和焦虑。当顾客经历色素沉淀治疗的负面副作用时,他们会对产品或服务失去信心。有负面经验的人可能会对公司或服务产生怀疑,并且可能不愿意寻求进一步的治疗。严重的安全问题可能会导致产品召回、法律诉讼和法规行动,从而阻碍市场成长。
许多文化和地区都有不同的美丽标准,而干净、平衡、有光泽的皮肤往往就是其中之一。市场上产品和服务的可得性以及对色素沉着过度治疗的需求可能会受到这些标准的显着影响。美感和化妆品的选择也受到文化美感的影响。提亮或淡化皮肤的护肤品和化妆品在某些地区很受欢迎,并且通常可以解决色素沉着问题。
掺杂或仿冒品可能含有危害顾客健康的危险或隐藏物质。这些产品可能会因皮肤发炎、过敏反应、烧烫伤或现有色素沉着疾病恶化而造成身体伤害和痛苦。购买劣质或仿冒品的顾客可能会蒙受经济损失。顾客可能会忍不住购买这些产品,这些产品通常以低价出售,并承诺节省费用。然而,该产品后来可能被证明是有害的或无用的,这会因金钱损失而扰乱市场。
由于封锁和安全问题,许多皮肤科诊所和医疗水疗中心在疫情爆发初期被迫暂时关闭或限制开放时间。结果,我的色素沉着治疗预约被取消或推迟。病人不想去医院,所以即使诊所重新开放,也只有少数预约。一些患者决定延后择期手术,包括色素沉着的治疗。许多皮肤科医生和皮肤护理专家已经开始提供虚拟咨询和远端医疗服务,作为适应不断变化的情况的一种方式。虽然这使得患者照护具有一定的连续性,但也为需要面对面咨询的治疗方法带来了挑战。
由于雷射治疗是色素沉淀的主流治疗方法,并且被广泛认为是治疗各种类型色素沉着的最佳方法之一,因此雷射治疗领域预计将出现良好的增长。雷射技术可瞄准并分解皮肤中多余的黑色素,减少黑斑的出现,使肤色更加均匀。皮肤护理和雷射技术的科学不断发展,有助于提供更安全、更有效的色素沉着雷射治疗。
由于皮肤诊所经常治疗色素沉着,因此预计皮肤诊所部分在预测期内将出现最高的年复合成长率。这些诊所的皮肤科医生和皮肤护理专家专门从事识别和管理各种皮肤状况(包括色素沉着)的工作。根据评估,您的医疗保健专业人员将制定客製化的治疗计划,其中可以包括一种或多种治疗方法。为了确保为患者提供最新、最有效的治疗方法,我们皮肤科诊所的皮肤护理专家随时了解皮肤科和皮肤护理科学的最新进展。
根据预测,在预测期内,亚太地区预计将占据最大的市场占有率,因为西方的美丽理想、更高的可支配所得和不断增加的皮肤护理知识是推动这一市场扩张的一些因素。过度暴露在阳光下是亚太地区色素沉淀的主要原因。因此,使用防晒油并保护自己免受阳光照射变得更加重要。此外,由于人们对皮肤科手术的兴趣日益浓厚以及人们对皮肤健康的认识不断提高,色素沉着过度市场正在扩大。
预计北美在预测期内的年复合成长率最高。这是因为皮肤科医生和皮肤护理专业人员使用 IPL(强烈脉衝光)疗法、Q 开关雷射、点阵雷射和其他雷射治疗来瞄准和分解多余的黑色素。北美拥有众多皮肤护理设施、医疗水疗中心和皮肤科诊所,配备最先进的设备,并由具有治疗色素沉着过度专业知识的合格专业人员组成。此外,太阳黑子、老年斑、黄褐斑和发炎后色素沉着 (PIH) 都是北美市场处理的色素沉淀型态。
According to Stratistics MRC, the Global Hyperpigmentation Treatment Market is accounted for $4.78 billion in 2023 and is expected to reach $9.61 billion by 2030 growing at a CAGR of 10.5% during the forecast period. The term "hyperpigmentation" describes the darkening of certain skin tone regions brought on by an excess of melanin, the pigment that gives skin its color. Numerous things, such as hormones, UV exposure, inflammation, and skin traumas, might contribute to it. The main goals of hyperpigmentation treatments are usually to level out the skin tone and minimize or remove excess pigment.
A greater understanding of skin health motivates people to adopt preventative measures against skin deterioration. This involves taking precautions against sun-induced hyperpigmentation, such as using sunscreen, dressing in protective clothes, and finding shade. The implementation of a comprehensive skin health plan advocates for the early diagnosis and treatment of disorders related to hyperpigmentation. People are more inclined to seek expert advice and treatment as soon as hyperpigmentation problems arise. A culture of self-care is fostered by awareness of skin health. People are more likely to follow regular skincare regimens that target hyperpigmentation and enhance the general health of their skin.
Customers may suffer psychologically and physically from a product's adverse impacts. There might be burns, skin irritation, allergic responses, or increasing hyperpigmentation. For those pursuing therapy, these side effects may cause pain, discomfort, and concern. Customers lose faith in a product or service when they suffer negative side effects from hyperpigmentation treatments. People who have had bad encounters may become skeptical of the company or service and be reluctant to seek out more care. Product recalls, legal action, and regulatory actions might result from serious safety concerns which hinder the market growth.
Many cultures and geographical areas have different standards of beauty, and clean, balanced, and glowing skins are frequently among them. The market's availability of goods and services, as well as the demand for hyperpigmentation treatments, may be significantly impacted by these criteria. Aesthetic and cosmetic choices are also influenced by cultural ideals of beauty. Products for skincare and cosmetics that brighten or lighten the skin are popular in specific areas and frequently address hyperpigmentation.
Products that are subpar or counterfeit may have dangerous or hidden substances that put customers' health at risk. These products have the potential to cause bodily injury and suffering due to skin irritations, allergic reactions, burns, or exacerbation of pre-existing hyperpigmentation disorders. Customers that purchase inferior or counterfeit goods may suffer financial damages. The promise of savings may entice customers to purchase these items, which are frequently sold at reduced costs. They could subsequently discover, though, that the product is hazardous or useless, in which case money would be lost thus impedes the market.
Due to lockdowns and safety concerns, numerous dermatological clinics and medical spas had to temporarily close or restrict their operational hours during the early phases of the epidemic. As a result, appointments for hyperpigmentation treatments were either cancelled or postponed. Patients were reluctant to visit hospitals, thus even once clinics reopened, fewer individuals were scheduled for appointments. Certain patients made the decision to postpone elective operations, including as treatments for hyperpigmentation. Many dermatologists and skincare specialists started providing virtual consultations and telemedicine services as a way to adjust to the changing circumstances. This made some continuity in patient care possible, but also presented difficulties for therapies that call for in-person consultations.
The laser treatment segment is estimated to have a lucrative growth, as the hyperpigmentation treatments is dominated by laser therapy, which is widely regarded as one of the best methods for treating different types of hyperpigmentation. Dark spots can be less noticeable and a more uniform skin tone can be attained by using laser technology to target and break down excess melanin in the skin. The science of skincare and laser technology is always evolving, which helps to provide safer and more efficient laser treatments for hyperpigmentation thus driving the market.
The skin clinics segment is anticipated to witness the highest CAGR growth during the forecast period, as Skin clinics frequently provide therapy for hyperpigmentation. Expert dermatologists and skincare specialists, who specialize in identifying and managing a variety of skin disorders, including hyperpigmentation, work in these clinics. Drawing on the evaluation, the medical professional will create a customized treatment program that can involve one or more therapy approaches. To guarantee that they are offering patients the most modern and efficient treatment alternatives, skincare specialists in skin clinics keep up to date on the most recent advancements in dermatology and skincare science.
Asia Pacific is projected to hold the largest market share during the forecast period due to western beauty ideals, more disposable wealth, and growing knowledge of skincare are some of the factors driving this expansion. Overexposure to the sun is a major cause of hyperpigmentation in the Asia Pacific area. As a result, using sunscreen creams and protecting oneself from the sun are now more important. Moreover, due to rising interest in dermatological procedures and rising awareness of skin health the market for hyperpigmentation market is growing.
North America is projected to have the highest CAGR over the forecast period, owing to Intense pulsed light (IPL) therapy, Q-switched lasers, fractional lasers, and other laser treatments are used by dermatologists and skincare specialists to target and breakdown excess melanin. North America is home to a sizable number of skincare facilities, medical spas, and dermatological clinics that are stocked with cutting-edge equipment and manned by qualified specialists with expertise in treating hyperpigmentation. In addition Sunspots, age spots, melasma, and post-inflammatory hyperpigmentation (PIH) are among the several forms of hyperpigmentation that are addressed in the North American market.
Some of the key players profiled in the Hyperpigmentation Treatment Market include: AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc, Candela Corporation, "DermaMed Solutions LLC, Dermavant Science Inc., Dr. Reddy's Laboratories Limited, Epionce, Galderma SA, Alvogen, Glenmark Pharmaceuticals Limited, Incyte Corporation, L'Oreal SA , Merz GmbH & Co. KGaA, Obagi Cosmeceuticals LLC, Pfizer Inc., Pierre Fabre Group, SkinCeuticals, Viatirs Inc. (Mylan N.V.) and Vital Esthetique
In October 2023, AbbVie announced that its Phase 2b study evaluating upadacitinib (RINVOQ®) in adults with non-segmental vitiligo (NSV) met the primary endpoint of percent change from baseline in the Facial Vitiligo Area Scoring Index (F-VASI) at week 24 with the 11 mg and 22 mg doses versus placebo.
In October 2023, Astellas Pharma Inc. and BioLabs Global, Inc. and Mitsui Fudosan announced that they have agreed on a tri-party memorandum of understanding to enhance the life science ecosystem in Tsukuba and Kashiwa-no-ha, Japan, world-renowned science hubs.
In September 2023, Bausch + Lomb Corporation a subsidiary of Bausch Health Companies Inc. announced that, in connection with the financing of its pending acquisition of XIIDRA® and certain other ophthalmology assets, Bausch + Lomb Escrow Corp.